1. Correlates and Prognosis of Early Recurrence After Catheter Ablation for Ventricular Tachycardia due to Structural Heart Disease
- Author
-
Alan F. Helmbold, Bruce A. Koplan, Laurence M. Epstein, Chirag R. Barbhaiya, William G. Stevenson, Keiichi Inada, Michifumi Tokuda, Usha B. Tedrow, Saurabh Kumar, Eue Keun Choi, Gregory F. Michaud, Roy M. John, Alan D. Enriquez, Koichi Nagashima, Kaity Y. Lin, and Jason S. Chinitz
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Heart Diseases ,Heart disease ,Radiofrequency ablation ,medicine.medical_treatment ,Catheter ablation ,Kaplan-Meier Estimate ,Ventricular tachycardia ,law.invention ,Recurrence ,Risk Factors ,law ,Physiology (medical) ,Internal medicine ,Odds Ratio ,medicine ,Humans ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Chi-Square Distribution ,business.industry ,Hazard ratio ,Dilated cardiomyopathy ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,Logistic Models ,Treatment Outcome ,Multivariate Analysis ,Catheter Ablation ,Tachycardia, Ventricular ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Anti-Arrhythmia Agents - Abstract
Background— Catheter ablation for ventricular tachycardia (VT) from structural heart disease has a significant risk of recurrence, but the optimal duration for in-hospital monitoring is not defined. This study assesses the timing, correlates, and prognostic significance of early VT recurrence after ablation. Methods and Results— Of 370 patients (313 men; aged 63.0±13.2 years) who underwent a first radiofrequency ablation for sustained monomorphic VT associated with structural heart disease from 2008 to 2012, sustained VT recurred in 81 patients (22%) within 7 days. In multivariable analysis, early recurrence was associated with New York Heart Association classification ≥III (odds ratio [OR] 1.90, 95% confidence interval [CI] 1.03–3.48; P =0.04), dilated cardiomyopathy (OR 1.93, 95% CI 1.03–3.57; P =0.04), prevalence of VT storm before the procedure (OR 2.62, 95% CI 1.48–4.65; P =0.001), a greater number of induced VTs (OR 1.24, 95% CI 1.07–1.45; P =0.006), and acute failure or no final induction test (OR 1.88, 95% CI 1.03–3.40; P =0.04). During a median of 2.5 (1.2, 4.0) years of follow-up, early VT recurrence was an independent correlates of mortality (hazard ratio 2.59, 95% CI 1.52–4.34; P =0.0005). Conclusions— Patients who have early recurrences of VT after ablation are a high risk group who may be identifiable from their clinical profile. Further study is warranted to define the optimal treatment strategies for this patient group.
- Published
- 2014
- Full Text
- View/download PDF